‌

US Patent 9938267 Heterocyclic inhibitors of glutaminase

Patent 9938267 was granted and assigned to Calithera Biosciences on April, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Calithera Biosciences

Current Assignee

Calithera Biosciences

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

99382670

Patent Inventor Names

Guy Laidig0

Timothy F. Stanton0

Lijing Chen0

Bindu Goyal0

Eric B. Sjogren0

Jim Li0

Date of Patent

April 10, 2018

Patent Application Number

157007960

Date Filed

September 11, 2017

Patent Primary Examiner

‌

Alicia L Otton

Patent abstract

The invention relates to novel heterocyclic compounds and pharmaceutical preparations thereof. The invention further relates to methods of treatment using the novel heterocyclic compounds of the invention.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9938267 Heterocyclic inhibitors of glutaminase

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API